Navigation Links
Lpath to Present at 34th Annual Canaccord Genuity Growth Conference

SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, today announced that Scott Pancoast, president and CEO, will present at the 34th Annual Canaccord Genuity Growth Conference on Wednesday, August 13, 2014 at 5:00 p.m. Eastern Time in Boston. The live webcast presentation and replay will be available by visiting the Investor section of the Lpath website at

About Lpath
San Diego-based Lpath, Inc. (NASDAQ: LPTN), an antibody-platform company, is the category leader in lipid-targeted therapeutics. The company's ImmuneY2™ drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. The company has developed four drug candidates, two of which – iSONEP™ for wet AMD and ASONEP™ for cancer—are currently being investigated in Phase 2 trials. The other candidates are an anti-lysophosphatidic acid antibody, LpathomabTM, which is expected to enter the clinic in 2015 for neuropathic pain and neurotrauma, and an anti-leukotriene antibody, AltepanTM, which is being studied in models of respiratory disease. For more information, visit

Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
2. Lpath Withdraws From Pfizers Process to Assign iSONEP Rights
3. Genomic Health to Present at the Canaccord Genuity 34th Annual Growth Conference
4. Lexicon To Present At The 2014 Wedbush Life Sciences Management Access Conference
5. Omeros to Present at the Wedbush PacGrow 2014 Life Sciences Management Access Conference
6. Guardant Health to Present at the WedBush 2014 Life Sciences Management Access Conference
7. Mast Therapeutics To Present At The Canaccord Genuity 34th Annual Growth Conference On August 14th
8. STAAR Surgical To Present At Wedbush And Canaccord Investor Conferences
9. KemPharm, Inc. to Present at the Canaccord Genuity 34th Annual Growth Conference
10. MEI Pharma To Present At Wedbush PacGrow Life Sciences And Canaccord Genuity Growth Conferences
11. Cynosure to Present at Canaccord Genuity 34th Annual Growth Conference
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... ... mental health and wellness consultation, has collaborated with Women’s Web – an ... reader’s queries on topics on mental and emotional well-being relationship, life balance, ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the perfect dish and pleasing the palates of attendees is of the utmost ... dish to a seasonal get-together, give these recipes a try this holiday season. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
Breaking Medicine News(10 mins):